Trainee Track Webinar Thursday, May 11, 2017

Trainee Track Webinar
Balancing Career and Personal Life: Establishing Priorities and Achieving Job Satisfaction
Thursday, May 11, 2017, 11am EDT (Montreal time)


  To view the recording of the presentation click here (You must be logged into the website)

Speaker:

Martha Pavlakis, MD
Medical Director of Kidney and Pancreas Transplantation
Associate Professor of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA, United States

Martha Pavlakis, MD

Moderator:

Yolanda Becker, MD, FACS
Vice President, United Network for Organ Sharing
Professor of Surgery
Director of Kidney and Pancreas Transplantation
University of Chicago
Chicago, IL, United States

Yolanda Becker, MD, FACS

Overview:

This topic is not just for women and not just for people with kids. The challenge of establishing priorities and achieving job satisfaction applies to everyone in this field. Burnout is more common among physicians than among other US workers. We will start the webinar by defining family as more than just the narrow nuclear family. In developing an understanding of the causes of burnout, we will maintain a healthy respect for a variety of life choices, cultural and socioeconomic differences. The importance of resilience will be discussed and we will finish with a discussion of resources in the work/life integration toolbox.


Martha Pavlakis - Biography:

Dr. Pavlakis graduated from SUNY at Buffalo School of Medicine and completed internal medicine training at Tufts New England Medical Center.  She then completed both a renal fellowship and clinical investigation fellowship at Beth Israel Hospital, researching gene expression in kidney transplant rejection. In 1999, after 3 years at Stanford Medical Center where she was a transplant nephrologist and had a research lab, she returned to the newly merged Beth Israel Deaconess Medical Center and became the medical director of kidney and pancreas transplantation. She is an associate professor of medicine at Harvard Medical School and has continued to publish scholarly articles in the field of kidney and pancreas transplantation and kidney donation. She is currently the region 1 representative to the UNOS Kidney Committee and serves on the American Society of Transplantation Education Committee.  She has three sons ranging in age from 16 to 23, has a daily meditation practice and has studied Iyengar yoga for the past 11 years.


Yolanda Becker - Biography:

Dr. Becker is vice president of the OPTN/UNOS board of directors and of the UNOS corporate affairs committee, additionally serving as a member of the nominating committee and the board governance subcommittee. She has chaired the policy oversight committee. She also has served on the membership and professional standards committee (MPSC) and its performance analysis and improvement subcommittee. She additionally has been a member of MPSC’s performance and certification, and certification maintenance workgroups, co-chairing the latter.

Dr. Becker has served as an elected member of the American Society of Transplantation (AST) board of directors, co-chairing its winter symposium, chairing its education committee and additionally serving on the minority affairs committee. She has served on the American Society of Transplant Surgeons (ASTS) scientific studies committee and on the AST/ASTS American Transplant Congress program planning committee. She also has served on the board of directors of the National Kidney Registry.

She earned her medical degree at the Johns Hopkins School of Medicine in Baltimore. Dr. Becker has received additional leadership training, completing the Executive Leaders in Academic Medicine program at Drexel University College of Medicine in Philadelphia.

Trainee Track Webinar Thursday, April 13, 2017

Trainee Track Webinar
Getting Your Research Published in High Impact Journals
Thursday, April 13, 2017, 11am EST (Montreal time)


  To view the recording of the presentation click here (You must be logged into the website)

Speaker:

Allan D. Kirk, MD, PhD
Professor of Surgery, Professor in the Department of Immunology, Professor in Pediatrics
Chair, Department of Surgery
Duke University School of Medicine
Durham, NC, United States

Allan D. Kirk, MD, PhD

Moderator:

Robert L. Fairchild, PhD
Professor of Molecular Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio
Professor of Pathology
Case Western Reserve University School of Medicine
Cleveland, Ohio, United States

Robert L. Fairchild, PhD

Overview:

This Webinar will provide an overview of medical publishing, particularly as it relates to transplantation. It will provide detail regarding the peer review process, introduce strategies for successfully navigating peer review and help demystify the process of journal review and publication.


Allan D. Kirk - Biography:

Allan D. Kirk is a native of Virginia Beach. He graduated from ODU in 1983, designated the Most Outstanding Senior in Biology, with a BS in Biology, summa cum laude. Thereafter, he received an MD and a PhD in Immunology from Duke University, where he also completed his surgery residency. He completed an organ transplant fellowship at the University of Wisconsin. Dr. Kirk served in the US Navy as a transplant surgeon and Chief of Transplant Research for the Armed Services Transplant Service in Washington, DC. During this time, he helped develop a new approach to preventing organ transplant rejection, known as costimulation blockade, and transitioned to the National Institutes of Health to develop this field further as Chief of their Transplantation Branch. In 2007, he moved to Emory University, as Vice Chair for Surgical Research, and in 2014, was appointed Chairman of the Department of Surgery at Duke University. He holds Professorships in Surgery, Pediatrics and Immunology and serves as Surgeon-in-Chief for the Duke University Health System. He has published >300 scientific manuscripts, and continues NIH- and FDA-sponsored investigations in organ transplantation, and DoD-sponsored work in limb replacement following combat amputation and immune management of catastrophic injury.  


Robert L. Fairchild - Biography:

Robert L. Fairchild received a doctorate in immunology at the University of Missouri-Columbia and completed a postdoctoral fellowship at the University of Colorado Health Sciences Center and the National Jewish Hospital for Allergy and Immunology in Denver. He is currently a Professor of Molecular Medicine in the Cleveland Clinic Lerner College of Medicine and Professor in the Department of Pathology at Case Western Reserve University School of Medicine in Cleveland, Ohio.

Dr. Fairchild has served terms as a member on 3 NIH study sections and is a former Chair of the Tumors, Transplantation, and Tolerance (TTT) study section. He is currently a Deputy Editor for both the American Journal of Transplantation and for the Journal of Immunology.

Dr. Fairchild is principal investigator on NIH-funded studies focused on the impact of endogenous CD8 memory T cell activity on allograft outcome and on mechanisms underlying antibody mediated rejection of renal allografts using mouse models as well as clinical samples. Dr. Fairchild is a member of the Clinical Trials for Organ Transplantation Consortium and Director of the Molecular Core for CTOT-19.

Trainee Track Webinar Thursday, March 9, 2017

Trainee Track Webinar
How to Write a Successful Clinical Science Grant
Thursday, March 9, 2017, 11am (Montreal time)


  To view the recording of the presentation click here (You must be logged into the website)

Speaker:

Peter Reese
Transplant Nephrologist and Epidemiologist
Associate Professor of Medicine
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA, USA

Peter Reese Headshot Copy

Moderator:

Matthew Levine
Assistant Professor
Division of Transplant Surgery
Perelman School of Medicine
University of Pennsylvania
Surgical Director Renal Transplantation
Children’s Hospital of Philadelphia
Philadelphia, PA, USA

Matthew Levine Headshot

Overview:

This Webinar will focus on the entire process of writing a clinical science grant, starting with a conceptual idea.


Peter Reese - Biography:

Peter Reese, MD, MSCE is a transplant nephrologist and epidemiologist. He is Associate Professor of Medicine (effective July 1 2017) at the University of Pennsylvania Perelman School of Medicine. His research focuses on: a) developing effective strategies to increase access to kidney transplantation, b) improving the process of selecting and caring for living kidney donors, c) determining outcomes of health policies on vulnerable populations with renal disease, including the elderly, and d) testing strategies to improve important health behaviors such as medication adherence. He chairs the Ethics Committee for the United Network for Organ Sharing (UNOS), which oversees organ allocation and transplant regulation in the US, and is an Associate Editor for the American Journal of Kidney Diseases. He is Co-Principal Investigator for the THINKER study, a pilot trial of kidney transplantation of hepatitis C positive kidneys into hepatitis C negative recipients (Clinicaltrials.gov: NCT02743897). His research funding has included grants from the NIH, the American Society of Transplantation, the American Society of Nephrology, and the Greenwall Foundation.


Matthew Levine - Biography:

Matthew Levine was raised in Houston, Texas. He attended college at Brown University and then the Medical Scientist Training Program for a combined MD and PhD at Yale University. While there, he completed his PhD dissertation in immunobiology in the laboratory of Charles Janeway Jr., with work focusing on the discovery of positive selection events in the peripheral development of B cells. He then went on to complete general surgery residency at the Massachusetts General Hospital and a fellowship in abdominal organ transplantation at the University of California, San Francisco. He joined the faculty at the University of Pennsylvania in March, 2009 in the division of transplant surgery performing renal, liver and pancreas transplants in adults and children. He is the surgical director of the CHOP renal transplant program. He is a member of the ASTS, AST, AASLD, and TTS, and serves as chair of the CME committee of the ASTS. He serves on the basic science committee of the Society of University Surgeons and is a Fellow of the American College of Surgeons. He serves on the editorial boards of the American Journal of Transplantation and Liver Transplantation.

His scientific work focuses on two broad areas. The first is the role that histone/protein acetylation and de-acetylation plays in the tolerance of end organ ischemic injury – predominantly kidney and liver. This work has been facilitated several grants from NIH/NIDDK with the work performed in collaboration with the laboratory of Wayne Hancock at the Children’s Hospital of Philadelphia. He has an additional focus on the impact of hormone manipulation on ischemic injury. The second broad aspect of scientific inquiry has focused on vascularized composite tissue allotransplantation models in mice with a focus on tolerance induction. This work has involved multiple collaborators and is funded by multiple grants from the Department of Defense. Overall, his focus in on scientific inquiry with significant translatable potential in human transplantation.

Trainee Track Webinar Thursday, April 6, 2017

Trainee Track Webinar
Transplantation and Private Practice: A Career Alternative and its Impact on Academic Recruitment
Thursday, April 6, 11am EST (Montreal time)


  To view the recording of the presentation click here (You must be logged into the website)

Speaker:  

Daniel C. Brennan
Professor of Renal Diseases
Director of Transplant Nephrology
Washington University School of Medicine
St. Louis, Missouri, United States

  Dan Brennan

Moderator:  

Larry Melton
Medical Director of Organ Transplant
Hackensack University Medical Center
Hackensack, New Jersey, United States

  larry melton

Daniel C. Brennan - Biography:

Daniel C. Brennan, MD, FACP, is the Alan A. and Edith L. Wolff Professor of Renal Diseases and the Director of Transplant Nephrology at Washington University School of Medicine in St. Louis, Missouri.  Dr. Brennan’s research interests are viral infections, induction immunosuppression therapy, pharmacoeconomic and outcome research in transplantation and islet transplantation. He has written more than 200 original publications and several textbooks in these areas.


Larry Melton - Biography:

Dr. Melton is the Medical Director of Organ Transplant at HackensackUMC.  He was previously the Medical Director of Kidney/Pancreas transplant at the Simmons Transplant Institute, Baylor University Medical Center in Dallas, TX.  His interests are kidney and pancreas transplantation, combined liver/kidney transplantation and kidney function in liver disease.  He is board certified in Internal Medicine, Nephrology and Critical Care Medicine.  He attended Baylor University followed by graduate work at the University of Texas Health Science Center in Dallas where he earned a PhD in physiology.  He went to medical school at the University of Texas Medical School in San Antonio and did his internship at Parkland Memorial Hospital in Dallas.  He then moved to Boston, MA where he did his nephrology and transplant training at the Beth Israel Hospital and remained on the faculty at Harvard Medical School for a year after completion of his training.  Following that, Dr. Melton took a position in Dallas where he worked with the transplant program at Baylor University Medical Center and was a senior partner and treasurer of Dallas Nephrology Associates.  While in Dallas, he was also a Professor of Internal Medicine at Texas A&M Medical School.  He was President of the Texas Transplantation Society and is active in the American Society of Transplantation.  He has served on the Board of Directors for the AST, as Chair of the Transplant Accreditation Committee, as well as several other committees including the Public Policy Committee.   Dr. Melton  testified before Congress for the AST in support of eliminating the 36 month limit on immunosuppressive medication coverage.  He has participated in multiple clinical research trials, has authored many papers and book chapters and served as the Co-Scientific Editor of Dialysis and Transplantation.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi